抑郁症的营养药随机对照试验中安慰剂反应的预测者
Rosemary Arnold1, Jenifer Murphy-Smith1, Chee H Ng1
1Professorial Unit, the Melbourne Clinic, Department of Psychiatry, University of Melbourne, Richmond 3121, Australia.
Journal of integrative medicine
|February 8, 2024
概括
高等教育,更好的健康状况和先前的抗抑郁药治疗失败预测了抑郁症试验中的安慰剂反应. 了解这些因素可以改善未来的抑郁症治疗临床试验设计.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 安慰剂反应显著影响抑郁症随机对照试验 (RCT).
- 高的安慰剂反应率使真正治疗效果的检测变得复杂.
- 了解安慰剂反应的预测因素对于优化试验设计至关重要.
研究的目的:
- 在营养药抑郁RCT中确定与安慰剂反应相关的参与者特征.
- 探索影响安慰剂反应的社会人口,临床和遗传因素.
- 在未来的抑郁症研究中,为减轻安慰剂效应的策略提供信息.
主要方法:
- 营养药抑郁RCT的二次分析 (n=69在安慰剂组).
- 研究了参与者特征 (教育,健康,婚姻状况,先前的治疗,招聘方法) 与安慰剂反应之间的关联.
- 利用线性混合效应模型分析蒙哥马利-阿斯伯格抑郁症评分表变化和遗传多态性 (TPH1).
主要成果:
- 更大的安慰剂反应与高等教育,更好的自我报告健康,婚姻,早期症状改善和多次失败的抗抑郁药疗法有关.
- 通过社交媒体招募和同时服用抗抑郁药物治疗并没有增加安慰剂反应.
- 在TPH1基因多态和安慰剂反应之间发现了微弱的关联,通过多次比较来减弱.
结论:
- 在营养药抑郁症试验中,几个因素预测了安慰剂反应.
- 识别这些预测因素可能有助于设计未来的试验,以提高试验灵敏度.
- 这项研究为改善抑郁症研究中治疗效应的检测能力提供了见解.
更多相关视频
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
517
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
54
相关概念视频
The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Antidepressant Drugs: MAOIs and Other Agents
230
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
230
G-protein Coupled Receptors
118.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.9K
Depressive Disorders: Etiology
102
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
102
